These results suggest that IEL T cells exerted the strong immune response against tumor organoids, and that old IEL CD4+ T cells exert their anti-tumor activity through MHC-II dependent antigen presentation with the help of other T cell fractions such as γδT or CD8+ T cells. The gene discussed is CD4; the disease is neoplasm.